logo

For the Inventor, By the Inventor

Corona Del Mar, CA, United States of America

Daniel Gill

This inventor holds 3 USPTO granted patents. Top assignee: Allergan, Inc.. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Gill. Retrieved from https://idiyas.com/inventor/daniel-gill-tnr8sutt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 33.3

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal3 out of 2,287 
 
Allergan, Inc.
 patents

Years Active: 2010-2011

Loading Chart...
3 patents (USPTO):Explore Patents
1. 8063087 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds (2011-11-22),
2. 8022226 - Nonsedating α-2 agonists (2011-09-20),
3. 7838545 - 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists (2010-11-23),

Title: The Innovative Contributions of Daniel Gill

Introduction

Daniel Gill is a notable inventor based in Corona Del Mar, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective agonists. With a total of 3 patents to his name, Gill's work has the potential to impact therapeutic practices.

Latest Patents

Gill's latest patents include innovative compounds such as 4-(substituted cycloalkylmethyl) imidazole-2-thiones and 4-(substituted cycloalkenylmethyl) imidazole-2-thiones. He has also developed 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds. One of his notable inventions is a selective agonist that includes a compound represented by Structure 1, which can be used in pharmaceutical compositions for therapeutic applications.

Career Highlights

Daniel Gill is currently associated with Allergan, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing compounds that can provide therapeutic benefits, particularly in the area of nonsedating α-2 agonists.

Collaborations

Gill has collaborated with notable colleagues such as Ken Chow and Todd M Heidelbaugh, contributing to a dynamic research environment that fosters innovation.

Conclusion

Daniel Gill's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…